According to the latest research by iData Research, the U.S. sports medicine market is limited by the relatively stable incidence rate of tendon and ligament injuries, which tends to vary greatly among different anatomies and different population groups. In spite of this trend, the level of innovation has been increasing within the U.S. sports medicine market
Within the U.S. small bone and joint devices market, the total market is composed of both reconstruction and internal fixation products. Both plate and screw devices are defined as internal fixations primarily indicated for the treatment of fractures. On the other hand, fixation products are similar to traumatic fixation devices, but they can be replaced
In 2021, the global large joint devices market generated a valuation of $19 billion. Despite the seemingly impressive valuation, the market is still growing and iData’s analysts predict that it will reach $26 billion by 2028. To date, several large competitors dominate the global large joints market. Zimmer Biomet, Stryker, and DePuy Synthes were able
iData’s analysts work extensively to retrieve data and source both syndicated and custom market research reports. Due to their in-depth understanding of the markets and their first-hand experience with the data, we have asked some insightful questions on the European market for orthopedic biomaterials to assist you in making better strategic decisions. WHAT ARE ORTHOPEDIC
CrossRoads® Extremity Systems surgical tools and implants are designed to address a broad variety of bunion deformities. The Tennessee-based foot and ankle company has officially announced that they will be joining the devices offered by DePuy Synthes, Johnson & Johnson’s orthopedics-focused subsidiary. DePuy Synthes announced the acquisition of the foot and ankle surgical device maker
A world first: using a nerve-stimulating device implanted into the spinal cord and controlled by a tablet, Swiss researchers have enabled three paraplegic patients to stand and walk again. Since 2018, technological innovation has proven that paralysis from spinal cord injury may be partly reversible, as using electrical implants on the spine seem to encourage
Within the U.S. Orthopedic Biomaterials market, multiple segments are discussed including bone graft substitutes, cellular allografts, and growth factors. Bone graft substitutes are designed to fill bone voids or act as extenders, thereby eliminating or decreasing the need for autograft harvesting. On the other hand, cellular allografts consist of allograft bone combined with adipose-derived mesenchymal
iData is excited to announce one of our brand-new 2022 market reports on the U.S. orthopedic biomaterials market. As expected, 2020 was an unusual year mainly due to the global COVID-19 pandemic, which caused a 6.7% decrease in the U.S. Orthopedic Biomaterials Market from 2019 to 2020. Despite a large majority of orthopedic surgeries
iData Research has conducted a thorough analysis on the varying market trends that follow the Minimally Invasive (MIS) Spinal Implants Market in Europe in comparison to the Open Spinal Implants Market. Though the two procedures exemplify similar characteristics with regard to their procedures, their market trends are drastically different and are forecasted to grow at
A Top-Level Analysis of Europe’s MDR iData’s analysts work extensively to collect data and insight from a variety of resources to create both syndicated and custom research reports for their successful clients world-wide. Owing to their in-depth understanding of the markets and first-hand experience with the appropriate data, our analysts have looked into the effects
